A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 5817
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : AVP
Long Form : arginine vasopressin
No. Year Title Co-occurring Abbreviation
2021 A Journey through the Early Evidence Linking Hydration to Metabolic Health. ---
2021 A metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremia. ApelinR
2021 Activation of Orexin 1 Receptors in the Paraventricular Nucleus Contributes to the Development of Deoxycorticosterone Acetate-Salt Hypertension Through Regulation of Vasopressin. DOCA, HR, MAP, OX1R, PVN, SSH
2021 Activation of V1a vasopressin receptors excite subicular pyramidal neurons by activating TRPV1 and depressing GIRK channels. ---
2021 Adipsic diabetes insipidus. ADI
2021 Aetiological diagnosis of hyponatraemia in non-critical patients on total parenteral nutrition: A prospective multicentre study. SIADH, SNa, TPN
2021 Aggregation of Aβ40/42 chains in the presence of cyclic neuropeptides investigated by molecular dynamics simulations. SST-14
2021 Altered offspring neurodevelopment in an arginine vasopressin preeclampsia model. DG
2021 Animal models for diabetes insipidus. CDI, NDI
10  2021 Arginine Vasopressin as an Important Mediator of Fluctuations in the Serum Creatinine Concentration Under Decongestion Treatment in Heart Failure Patients. BNP, HF, SCr
11  2021 Arginine Vasopressin-Containing Neurons of the Suprachiasmatic Nucleus Project to CSF. CSF, CTbeta, LV, SCN
12  2021 Arginine vasopressin-Venus reporter mice as a tool for studying magnocellular arginine vasopressin neurons. ---
13  2021 Arginine vasopressin: Direct and indirect action on metabolism. ---
14  2021 Arginine-vasopressin infusion in a child with cranial diabetes insipidus during hyperhydration therapy with chemotherapy: a therapeutic challenge. ---
15  2021 Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred. FNDI
16  2021 Cardiovascular Neuroendocrinology: Emerging Role for Neurohypophyseal Hormones in Pathophysiology. OXY
17  2021 Changes in copeptin levels before and 3 months after transsphenoidal surgery according to the presence of postoperative central diabetes insipidus. CDI
18  2021 Chemogenetic activation of endogenous arginine vasopressin exerts anorexigenic effects via central nesfatin-1/NucB2 pathway. s.c
19  2021 Chronic Exercise Protects against the Progression of Renal Cyst Growth and Dysfunction in Rats with Polycystic Kidney Disease. ERK, mTOR, PCK, PKD
20  2021 Co-Stimulation of Oxytocin and Arginine-Vasopressin Receptors Affect Hypothalamic Neurospheroid Size. OXT, OXTR
21  2021 Comparison of Vasopressin versus Norepinephrine in a Pig Model of Refractory Cardiogenic Shock Complicated by Cardiac Arrest and Resuscitated with Veno-arterial ECMO. ECMO, MAP, NE
22  2021 Copeptin as a novel biomarker of the cardiometabolic syndrome. ACTH, ADH
23  2021 Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease. ADPKD, AGT, APLN, EGF, eGFR, ESKD, VEGFA
24  2021 Cryo-electron microscopy structure of the antidiuretic hormone arginine-vasopressin V2 receptor signaling complex. GPCR, V2R
25  2021 Daily and Estral Regulation of RFRP-3 Neurons in the Female Mice. ---
26  2021 Deficiency of WFS1 leads to the impairment of AVP secretion under dehydration in male mice. CDI, ER, WD, WS
27  2021 Degradation of Premature-miR-181b by the Translin/Trax RNase Increases Vascular Smooth Muscle Cell Stiffness. VSMCs
28  2021 Development of a sensitive liquid chromatography-tandem mass spectrometry method for quantification of human plasma arginine vasopressin. LLOQ, RIA
29  2021 Diabetes Insipidus: A Pragmatic Approach to Management. ADH, DI
30  2021 Diagnosis and management of diabetes insipidus for the internist: an update. ---
31  2021 Differential diagnosis of familial diabetes insipidus. DI
32  2021 Doublecortin-like expressing astrocytes of the suprachiasmatic nucleus are implicated in the biosynthesis of vasopressin and influences circadian rhythms. DCL, GAT3, SCN, sh, TEM, WT
33  2021 Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review. ---
34  2021 Estrous Cycle Plasticity in the Central Clock Output to Kisspeptin Neurons: Implications for the Preovulatory Surge. SCN
35  2021 Exercise-induced hypercalcemia and vasopressin-mediated bone resorption. tCa, TRACP-5b
36  2021 Exogenous central angiotensin fails to stimulate a sodium appetite in diabetes insipidus Brattleboro rats. Ang II, DI, LE, OT, SSA
37  2021 Exploring immunoreactivity of TTF-1 and AVP in hypothalamic hamartoma. HH
38  2021 Familial neurohypophyseal diabetes insipidus: clinical, genetic and functional studies of novel mutations in the arginine vasopressin gene. FNDI, NPII
39  2021 GABA from vasopressin neurons regulates the time at which suprachiasmatic nucleus molecular clocks enable circadian behavior. GABA, SCN
40  2021 Hyponatremia in heart failure: not just 135 to 145. HF
41  2021 Imaging pituitary vasopressin 1B receptor in humans with the novel PET radiotracer 11C-TASP699. aTRV, MA1, TRV, TRV, V1BR
42  2021 Increased oxytocin release precedes hyponatremia after pituitary surgery. OXT, SIADH
43  2021 Intranasal vasopressin modulates resting state brain activity across multiple neural systems: Evidence from a brain imaging machine learning study. ALFF
44  2021 Involvement of TRPC5 channels, inwardly rectifying K+ channels, PLCβ and PIP2 in vasopressin-mediated excitation of medial central amygdala neurons. CeM, PLCbeta
45  2021 Local cyclic adenosine monophosphate signalling cascades-Roles and targets in chronic kidney disease. AKAPs, cAMP, CKD, PDEs
46  2021 Minimally invasive brain injections for viral-mediated transgenesis: New tools for behavioral genetics in sticklebacks. MAOA
47  2021 Nephrogenic diabetes insipidus in children (Review). AQP2, COX, NDI, NSAIDs
48  2021 Nocturnal enuresis in children: The role of arginine-vasopressin. ---
49  2021 NPAS4 regulates the transcriptional response of the suprachiasmatic nucleus to light and circadian behavior. CCK, PAS, SCN, VIP
50  2021 Opposing responses of the rat pulmonary artery and vein to phenylephrine and other agents in vitro. L-NAME
51  2021 Oxytocin and vasopressin within the ventral and dorsal lateral septum modulate aggression in female rats. dLS, LS, OXT, vLS
52  2021 Postnatal AVP treatments prevent social deficit in adolescence of valproic acid-induced rat autism model. CSF, PVN, VPA
53  2021 Presynaptic inputs to vasopressin neurons in the hypothalamic supraoptic nucleus and paraventricular nucleus in mice. PVN, SON
54  2021 Psychoendocrinology: arginine vasopressin and resilience in patients with major depressive disorder. ELISA, MDD
55  2021 Roles of Neuropeptides, VIP and AVP, in the Mammalian Central Circadian Clock. Cry, SCN, VIP
56  2021 Roles of PLCβ, PIP2 , and GIRK channels in arginine vasopressin-elicited excitation of CA1 pyramidal neurons. PLCbeta
57  2021 Specification of oxytocinergic and vasopressinergic circuits in the developing mouse brain. OXT
58  2021 The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes. ACLD, aHR, BNP, HVPG, PH, RAA
59  2021 The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study. ---
60  2021 Tolvaptan-induced remission of primary palmar hyperhidrosis in a patient with ADPKD: a serendipitous finding. ACTH, ADPKD, CRF
61  2021 Transcription Factor TonEBP Stimulates Hyperosmolality-Dependent Arginine Vasopressin Gene Expression in the Mouse Hypothalamus. TonEBP
62  2021 Transforming growth factor-beta and liver injury in an arginine vasopressin-induced pregnant rat model. NAVP, NS, PAVP, PS, TGF-beta
63  2021 Unusual ischemic kidney injury presenting as slowly declining graft function and successful use of oral desmopressin in a kidney transplant recipient with subclinical central diabetes insipidus. CDI, KT
64  2021 Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical trials. CV, HF, TV
65  2021 Vasopressin Neurons Respond to Hyperosmotic Stimulation with Regulatory Volume Increase and Secretory Volume Decrease by Activating Ion Transporters and Ca2+ Channels. EGFP, MNCs, OXT, RVD, RVI, SVD
66  2021 Vasopressin V1B Receptor Antagonists as Potential Antidepressants. HPA
67  2021 Vasopressin-Dependent Disorders: What Is New in Children? DI, SIADH
68  2021 Weight-reducing, lipid-lowering and antidiabetic activities of a novel arginine vasopressin analogue acting at the V1a and V1b receptors in high-fat-fed mice. ---
69  2021 WITHDRAWN: Age-dependent modulation of RFRP-3 neurons in female mice. LH, RFRP-3, VIP
70  2021 [Role of prostaglandin E2 in the modulation of renal water transport]. AQP2, PGE2
71  2020 A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus. AQP2, NDI, V2R
72  2020 A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production. DI
73  2020 A sellar neuroblastoma showing rapid growth and causing syndrome of inappropriate secretion of antidiuretic hormone: A case report. MRI
74  2020 Abrupt Discontinuation Versus Down-Titration of Vasopressin in Patients Recovering from Septic Shock. ICU
75  2020 Activation of Preoptic Arginine Vasopressin Neurons Induces Hyperthermia in Male Mice. MPO, PACAP
76  2020 Acute Mono-Arthritis Activates the Neurohypophysial System and Hypothalamo-Pituitary Adrenal Axis in Rats. CRH, HPA, ir, OXT, PVN
77  2020 Advances in Aquaporin-2 trafficking mechanisms and their implications for treatment of water balance disorders. AQP2
78  2020 Agonist-induced formation of unproductive receptor-G12 complexes. BRET, GPCRs, GRK, Smo, V2R
79  2020 AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions. AQP2, AVPR2, NDI
80  2020 Arginine Vasopressin Modulates Ion and Acid/Base Balance by Regulating Cell Numbers of Sodium Chloride Cotransporter and H+-ATPase Rich Ionocytes. CGRP, crlr1, HR, MO, NaR
81  2020 Arginine vasopressin receptor 2 activation promotes microvascular permeability in sepsis. HMVECs, MRSA, PLCbeta, TLVP, V1R
82  2020 Arginine vasotocin affects vocal behavior but not selective responses to conspecific calls in male túngara frogs. AVT
83  2020 Arginine vasotocin impacts chemosensory behavior during social interactions of Anolis carolinensis lizards. AVT, AVT
84  2020 AVPR1A distribution in the whole C57BL/6J mouse neonate. AVPR1a, KO, WT
85  2020 Binding affinities of oxytocin, vasopressin and Manning compound at oxytocin and V1a receptors in male Syrian hamster brains. CI, OT
86  2020 Biological variation of arginine vasopressin. ---
87  2020 Cardiac output improvement by pecavaptan: a novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failure. CO, HF
88  2020 Cardiovascular and renal effects of constant rate infusions of remifentanil, dexmedetomidine and their combination in dogs anesthetized with sevoflurane. MAC
89  2020 Central Diabetes Insipidus Caused by Arginine Vasopressin Gene Mutation: Report of a Novel Mutation and Review of Literature. FNDI
90  2020 Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapy. CDI, CTLA-4, DDAVP
91  2020 Clinical Characteristics of Pediatric Patients With Sellar and Suprasellar Lesions Who Initially Present With Central Diabetes Insipidus: A Retrospective Study of 55 Cases From a Large Pituitary Center in China. CDI, SSR
92  2020 Comparative study of the volume of the temporal lobe sections and neuropeptide effect in Alzheimer's patients and healthy persons. AD, OT, PHG_R
93  2020 Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor. CHO, FMP, hV1aR, OT, OTR, V1aR
94  2020 Copeptin - a new diagnostic and prognostic biomarker in neurological and cardiovascular diseases. AMI, HF
95  2020 Copeptin and mid-regional pro-atrial natriuretic peptide in women with suspected or confirmed pre-eclampsia: comparison with sFlt-1/PlGF ratio. ANP, MR-proANP, PE, PlGF, sFlt-1
96  2020 Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes. eGFR, ESKD, T1D
97  2020 Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5. CAC, CKD, CKD5, CVD, HD, PD, VC
98  2020 Copeptin Kinetics and Its Relationship to Osmolality During Rehydration for Diabetic Ketoacidosis in Children. BSV, DKA, T1D
99  2020 Copeptin response to hypoglycemic stress is linked to prolactin activation in children. IL-6
100  2020 Cullin RING Ligase 5 (CRL-5): Neddylation Activation and Biological Functions. CRL-5, Cul5, NAE, VACM-1